Disclosures: Marie-Agns M'CALLUM: Nothing to Disclose, Quang Toan PHAM: Nothing to Disclose, Kristen Vieira-Lomasney: Nothing to Disclose, Eytan Haddad: Nothing to Disclose, Silvia Selleri: Abcellera Biologics: Employee, Massimiliano Paganelli: Morphocell Technologies: Executive role 1162 ASSOCIATION OF GLUCAGON-LIKE PEPTIDASE 1 RECEPTOR AGONIST WITH LIVER AND NON-LIVER COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE Mindie Nguyen 1 Xianhua Mao 1 Xinrong Zhang 1 Rongtao Lai 2 Ka-Shing Cheung 3 Man-Fung Yuen 3 Ramsey Cheung 1 Wai-Kay Seto 3 , 1 Stanford University Medical Center, 2 Shanghai Jiao Tong University School of Medicine, 3 The University of Hong Kong Background: Although individuals with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease (diabetic MASLD) face a higher lifelong risk of developing liver and non-liver morbidities, there so far are limited effective pharmacological strategies to reduce the disease burden in this population

What's more, constant, high-intensity physical activity causes wear and tear in the connective tissues
Doktorarbeit am Physiologischen Institut der Tierrztlichen Hochschule Hannover (2000)
Glutathione works to brighten, refine texture, and even skin tone, while Vitamin C reduces the appearance of dark spots, boosts collagen, and promotes a youthful glow
Many strains of lactic acid bacteria (LAB) have been used as antifungal and anti-mycotoxigenic medicines because they inhibit fungi and absorb their toxins (Sadiq et al
Researchers noted this when they found that ghrelin deficient mice had fewer blood vessels in their white fat tissue than other mice [8]